[go: up one dir, main page]

DK173590D0 - Rekombinante terapeutiske lipaser - Google Patents

Rekombinante terapeutiske lipaser

Info

Publication number
DK173590D0
DK173590D0 DK173590A DK173590A DK173590D0 DK 173590 D0 DK173590 D0 DK 173590D0 DK 173590 A DK173590 A DK 173590A DK 173590 A DK173590 A DK 173590A DK 173590 D0 DK173590 D0 DK 173590D0
Authority
DK
Denmark
Prior art keywords
lipases
recombinant therapeutic
lipase
prophylaxis
mammals
Prior art date
Application number
DK173590A
Other languages
English (en)
Inventor
Birgitte Huge-Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK137990A external-priority patent/DK137990D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK173590A priority Critical patent/DK173590D0/da
Publication of DK173590D0 publication Critical patent/DK173590D0/da
Priority to FI925530A priority patent/FI925530L/fi
Priority to AT91910966T priority patent/ATE178492T1/de
Priority to AU80964/91A priority patent/AU645583B2/en
Priority to EP91910966A priority patent/EP0600868B1/en
Priority to JP03510710A priority patent/JP3072853B2/ja
Priority to PCT/DK1991/000149 priority patent/WO1991018623A1/en
Priority to CA002084184A priority patent/CA2084184A1/en
Priority to DE69131106T priority patent/DE69131106T2/de
Priority to US08/318,036 priority patent/US5614189A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK173590A 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser DK173590D0 (da)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DK173590A DK173590D0 (da) 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser
DE69131106T DE69131106T2 (de) 1990-06-06 1991-06-04 Gentechnologisch hergestellte lipasen für die therapeutische behandlung
CA002084184A CA2084184A1 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
AU80964/91A AU645583B2 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
AT91910966T ATE178492T1 (de) 1990-06-06 1991-06-04 Gentechnologisch hergestellte lipasen für die therapeutische behandlung
FI925530A FI925530L (fi) 1990-06-06 1991-06-04 Rekombinantiskt framstaellda lipaser foer terapeutiskt bruk
EP91910966A EP0600868B1 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
JP03510710A JP3072853B2 (ja) 1990-06-06 1991-06-04 治療用に、組換方法で生産されたリパーゼ
PCT/DK1991/000149 WO1991018623A1 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
US08/318,036 US5614189A (en) 1990-06-06 1994-10-04 Recombinantly produced lipases for therapeutical treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK137990A DK137990D0 (da) 1990-06-06 1990-06-06 Rekombinante terapeutiske lipaser
DK173590A DK173590D0 (da) 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser

Publications (1)

Publication Number Publication Date
DK173590D0 true DK173590D0 (da) 1990-07-19

Family

ID=26065679

Family Applications (1)

Application Number Title Priority Date Filing Date
DK173590A DK173590D0 (da) 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser

Country Status (10)

Country Link
US (1) US5614189A (da)
EP (1) EP0600868B1 (da)
JP (1) JP3072853B2 (da)
AT (1) ATE178492T1 (da)
AU (1) AU645583B2 (da)
CA (1) CA2084184A1 (da)
DE (1) DE69131106T2 (da)
DK (1) DK173590D0 (da)
FI (1) FI925530L (da)
WO (1) WO1991018623A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
JP5032300B2 (ja) 2004-03-22 2012-09-26 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 界面活性剤を含有している、リパーゼを含有する生成物の、とりわけパンクレアチンの経口医薬組成物
DK1755656T3 (da) * 2004-05-24 2010-10-04 Novozymes As Enzymer til farmaceutisk anvendelse
SI1809320T1 (sl) 2004-10-14 2010-11-30 Cystic Fibrosis Foundation Therapeutics Inc Sestavki ki vsebujejo lipazo proteazo in amilazo za zdravljenje pankreasne insuficience
CN101242853A (zh) 2005-06-24 2008-08-13 诺维信公司 用于药物用途的淀粉酶
KR20080017025A (ko) * 2005-06-24 2008-02-25 노보자임스 에이/에스 약학적 용도의 리파제
RU2420578C2 (ru) * 2005-06-24 2011-06-10 Новозимс А/С Протеазы для фармацевтического применения
AU2006274835B2 (en) * 2005-07-29 2012-05-24 Abbott Laboratories Gmbh Processes for the manufacture of sterilized pancreatin powder
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
WO2007053619A2 (en) 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
RU2009128067A (ru) * 2006-12-21 2011-01-27 Новозимс А/С (Dk) Варианты липаз для их применения в фармацевтике
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2009071550A1 (en) * 2007-12-04 2009-06-11 Novozymes A/S Protease variants for pharmaceutical use
EP2237771A1 (en) * 2008-01-03 2010-10-13 Abbott Products GmbH Pharmaceutical compositions comprising granules of purified microbial lipase and methods of preventing or treating digestive disorders
BRPI0922653B8 (pt) 2009-01-29 2021-05-25 Nordmark Arzneimittel Gmbh & Co Kg uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa
WO2011000924A1 (en) 2009-07-03 2011-01-06 Abbott Products Gmbh Spray-dried amylase, pharmaceutical preparations comprising the same and use
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
CN105392496A (zh) * 2013-07-22 2016-03-09 阿普塔利斯制药有限公司 高效的胰酶药物组合物
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
GB201501081D0 (en) * 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
WO2016126970A1 (en) 2015-02-04 2016-08-11 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
DE102015114857A1 (de) * 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421210D0 (en) * 1984-08-21 1984-09-26 Celltech Ltd Polypeptide and polypeptide composition
US4659667A (en) * 1985-02-26 1987-04-21 Miles Laboratories, Inc. Process to recover crystalline enzymes and crystalline enzymes produced thereby
US5108457A (en) * 1986-11-19 1992-04-28 The Clorox Company Enzymatic peracid bleaching system with modified enzyme
DE3854249T2 (de) * 1987-08-28 1996-02-29 Novonordisk As Rekombinante Humicola-Lipase und Verfahren zur Herstellung von rekombinanten Humicola-Lipasen.
ES2044718T3 (es) * 1989-12-21 1994-01-01 Novo Nordisk As Preparacion que contiene enzimas y detergente que contiene dicha preparacion.

Also Published As

Publication number Publication date
EP0600868B1 (en) 1999-04-07
JPH06501147A (ja) 1994-02-10
DE69131106D1 (de) 1999-05-12
AU8096491A (en) 1991-12-31
DE69131106T2 (de) 1999-11-18
JP3072853B2 (ja) 2000-08-07
FI925530A0 (fi) 1992-12-04
EP0600868A1 (en) 1994-06-15
FI925530A7 (fi) 1992-12-04
US5614189A (en) 1997-03-25
WO1991018623A1 (en) 1991-12-12
ATE178492T1 (de) 1999-04-15
CA2084184A1 (en) 1991-12-07
AU645583B2 (en) 1994-01-20
FI925530L (fi) 1992-12-04

Similar Documents

Publication Publication Date Title
DK173590D0 (da) Rekombinante terapeutiske lipaser
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
MY101842A (en) Treatment of oral diseases.
ES2007625A6 (es) Un procedimiento para la produccion de una proteina para huesos y cartilagos.
DK0611522T3 (da) Synergistiske mikrobicide sammensætninger
AU563748B2 (en) Quinolone carboxylic acids
PT764167E (pt) Inibidor biciclico de lactama do enzima de conversao da beta-interleucina-1
JPS5799576A (en) 3-(p-alkylsulfonylphenyl)oxazolidinone derivatives
PL321848A1 (en) Cell adhesion inhibitors
CA2119562A1 (en) Method and compositions for the treatment of cerebral palsy
CA2211120A1 (en) Lineage-directed induction of human mesenchymal stem cell differentiation
MY117526A (en) N-(3-benzofuranyl)urea-derivatives
AP9100310A0 (en) Tnf inhibitors
CA2267932A1 (en) Compositions for postgastrectomic mineral supply
DE69432573D1 (de) Inhibitoren des Endothelin konvertierenden Enzyms
NO171634C (no) Analogifremgangsmaate for fremstilling av alfa-aryl-4-(4,5-dihydro-3,5-diokso-1,2,4-triazin-2(3h)-yl)-benzenacetonitriler
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
FI970203A0 (fi) Pyridyylitioyhdisteet helikobakteerien torjumiseksi
ES8504775A1 (es) Un metodo de preparar compuestos de diaminopirimidina
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
NO177055C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-oksetanoner
GR3015470T3 (en) Inhibitors of lysyl oxidase.
EP0618812A4 (en) USE OF PROTEASE NEXIN-I AS ANTI-INFLAMMATORY.
EP0297816A3 (en) Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
MX9605327A (es) Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
B1 Patent granted (law 1993)
PUP Patent expired